Rupp, Tobias
von Vopelius, Emil
Strahl, André
Oheim, Ralf
Barvencik, Florian
Amling, Michael
Rolvien, Tim
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 24 February 2022
Accepted: 13 June 2022
First Online: 25 June 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Ethical approval for this retrospective study was obtained from the local ethics committee. The study reports according to the STROBE guidelines for reporting observational studies. Informed consent was obtained from all individual participants included in the study.
: Tobias Rupp, Emil von Vopelius, André Strahl, Florian Barvencik, Michael Amling and Tim Rolvien declare that they have no conflict of interest. Ralf Oheim has served as a speaker and advisory board member for Kyowa Kirin, Inozyme and UCB and has received an institutional research grant from Kyowa Kirin and UCB.